Eight healthy babies have been born following mitochondrial transfer, which creates “three-parent” embryos, in the world’s first clinical assessment of the treatment developed to reduce the risk of DNA diseases.
Genetic defects in mitochondrial DNA affect about one baby in 5,000, leading to a wide range of medical problems from muscle atrophy to heart failure and brain disease.
您已閱讀13%（514字），剩餘87%（3350字）包含更多重要資訊，訂閱以繼續探索完整內容，並享受更多專屬服務。